NCT01711177View on ClinicalTrials.gov

Effect of Travoprost 0.004% on Retinal Oximetry in Primary Open Angle Glaucoma

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Primary Open Angle Glaucoma
Interventions
DRUG

placebo

Placebo

DRUG

travoprost

Travatan Z is administered to newly diagnosed glaucoma patient

Trial Locations (1)

H3t1P1

University of Montreal, Montreal

All Listed Sponsors
lead

Université de Montréal

OTHER

NCT01711177 - Effect of Travoprost 0.004% on Retinal Oximetry in Primary Open Angle Glaucoma | Biotech Hunter | Biotech Hunter